Open AccessNew Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized patients: A pilot study
Author(s) -
Shyam Sunder Grover,
Ananya Doda,
Nidhi Gupta,
Inderjeet Gandhoke,
Jyoti Batra,
Charoo Hans,
Shashi Khare
Publication year - 2017
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/ijmr.ijmr_594_15
Subject(s) - escherichia coli , microbiology and biotechnology , biology , antimicrobial , carbapenem , new delhi , polymerase chain reaction , minimum inhibitory concentration , gene , antibiotics , medicine , genetics , metropolitan area , pathology
Resistances to carbapenem group of antimicrobials among Escherichia coli due to production of carbapenemases, especially the New Delhi metallo-β-lactamase (NDM) types, pose serious challenges in the treatment of infections in healthcare settings. This study was undertaken to detect NDM producing E. coli isolates from hospitalized patients with urinary tract infection (UTI).